Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 745-756 of 4,306
Drug study icon
CompletedEUCTR 2018-003825-27

A Phase 2, Randomized, Double-Blind, Multiple-Dose, Placebo-Controlled Study to Evaluate the Safety and Efficacy of BIIB104 in Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, United Kingdom, Germany, ...
Sponsor
Biogen Idec Research Limited
Condition
Schizophrenia
Drug study icon
TerminatedISRCTN77257074

Augmentation of antipsychotic medication with anticonvulsant in the management of treatment resistant schizophrenia

This public ISRCTN record appears to relate to schizophrenia. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
Behavioral study icon
Active Not RecruitingNCT05877716

EPI-MINN: Targeting Cognition and Motivation - National

This study is looking at whether psychoeducation can help people with depression, psychosis, or bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

In Minneapolis
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, Bipolarity, ...BehavioralFrom 15 Years to 40 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia, Bipolarity, ...
Device study icon
Not recruitingISRCTN72210184

Double-blind randomised controlled trial of repetitive Transcranial Magnetic Stimulation in the treatment of persistent auditory hallucinations for schizophrenia

This study is not recruiting in the United Kingdom. It is testing double-blind randomised controlled trial of repetitive Transcranial Magnetic Stimulation in the treatment of persistent auditory hallucinations for schizophrenia.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Department of Health (UK)
Condition
Schizophrenia
Drug study icon
Not recruitingISRCTN33909010

Placebo- and active comparator-controlled, study to study the safety and efficacy of two doses of lurasidone HCL in acutely psychotic people with schizophrenia

This study is not recruiting in the United Kingdom, in Bulgaria, in Colombia, .... It focuses on schizophrenia.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, Bulgaria, Colombia, ...
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
Drug study icon
Not recruitingISRCTN44297014

A phase III active comparator-controlled study to study the safety and efficacy of lurasidone in subjects with schizophrenia (PEARL 3 extension study)

This study is not recruiting in the United States, in Colombia, in Germany, .... It focuses on schizophrenia.

In Colombia
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
United States, Colombia, Germany, ...
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
Drug study icon
Not recruitingISRCTN16838597

A phase three study to study the safety and efficacy of three doses of lurasidone hydrochloride (HCl) in acutely psychotic people with schizophrenia

This study is not recruiting in the United States, in France, in the United Kingdom, .... It focuses on schizophrenia.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
Other study type icon
Not recruitingISRCTN56877013

Effectiveness of usual, facility based care compared to an additional collaborative community care package in schizophrenia

This study is not recruiting in the United Kingdom and in India. It is testing usual, facility based care compared to an additional collaborative community care package for schizophrenia.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, India
Sponsor
Kings College London (UK)
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.